Why Temasek’s Bet on Indian Family Businesses Signals a New Era for Fertility Innovations

Exploring how Temasek’s increased investment in Indian family-run businesses could drive innovation in fertility services, reflecting broader market shifts and opportunities for companies like MakeAMom. [...]

How Citizens Financial’s $1.5B Buyback & Merck’s FDA Win Signal New Hope for Fertility Tech Innovators

Explore how recent financial moves by Citizens Financial and FDA approval for Merck are shaping the landscape of fertility technology investments, offering fresh optimism for affordable, at-home insemination solutions. [...]